Document Detail


Neutralizing influenza antibodies, IgA and total protein in the nasopharyngeal secretions of subjects vaccinated by nasal route with the inactivated influenza vaccine prepared in the "Stefan S. Nicolau" Institute of Virology.
MedLine Citation:
PMID:  111408     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Intranasal administration of two doses of the inactivated influenza vaccine prepared in the "Stefan S. Nicolau" Institute of Virology was followed by rises in the level of neutralizing secretory influenza antibodies in 82% of the cases. The concomitant study of secretory antibody, IgA and total protein levels, as well as of the serum HAI influenza antibodies demonstrated that their evolution was parallel only in 23% of the vaccinees. The percentage of secretory antibody conversion was similar to the rate of protection conferred by the vaccine.
Authors:
A Petrescu; A Mihail; I Samuel; O Teodosiu; G Isaia; E Ganea; C Motaş
Related Documents :
219688 - Impact of swine influenza vaccine on serum antibody.
17032238 - Impact of influenza vaccine formulation with a detailed analysis of the cytokine response.
9284718 - Dehydroepiandrosterone treatment is not beneficial to the immune response to influenza ...
12792158 - Temporal surveillance of the humoral immunity against influenza vaccine in the elderly ...
17302188 - Human papillomavirus vaccine: a new chance to prevent cervical cancer.
20978378 - Novel adenovirus vector-based vaccines for hiv-1.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Virologie     Volume:  30     ISSN:  0253-181X     ISO Abbreviation:  Virologie     Publication Date:    1979 Apr-Jun
Date Detail:
Created Date:  1979-09-25     Completed Date:  1979-09-25     Revised Date:  2013-05-07    
Medline Journal Info:
Nlm Unique ID:  7605765     Medline TA:  Virologie     Country:  ROMANIA    
Other Details:
Languages:  eng     Pagination:  109-15     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Intranasal
Antibodies, Viral / analysis*
Antibody Formation
Blood Proteins / analysis
Humans
Immunodiffusion
Immunoglobulin A / metabolism*
Immunoglobulin A, Secretory / metabolism*
Influenza Vaccines / administration & dosage*
Influenza, Human / immunology*,  prevention & control
Nasopharynx / analysis,  immunology
Chemical
Reg. No./Substance:
0/Antibodies, Viral; 0/Blood Proteins; 0/Immunoglobulin A; 0/Immunoglobulin A, Secretory; 0/Influenza Vaccines

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Toxic epidermal necrolysis in a monkey (Macaca fascicularis).
Next Document:  Assessment of the results of treating II- and III-stage cervical cancer, parametrial variant, by usi...